Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2005 / Cilt: 31 - Sayı: 4

Evaluation of sexual dysfunction in patients with luts, relationship with testosterous, leptin and and serum lipid levels: Re-evaluation after alpha blocker treatment abstract

Alt üriner sistem semptomlu hastalarda cinsel disfonksiyonun araştırılması, testosteron, leptin, kan lipidleri ile ilişkisi: Alfa bloker (Tamsulosin) tedavisi sonrası yeniden değerlendirme

Pages
508–515
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Leptin levels might be important in predicting LUTS and ED relationship for future research.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Lower urinary tract symptoms (LUTS) associated with BPH and erectile dysfunction (ED) are common problems in aging male.
📊
Key Findings & Data:Materials and Methods: Between June 2003 and February 2004, 46 patients were recruited in this study.
💡
Conclusion & Impact:Leptin levels might be important in predicting LUTS and ED relationship for future research.
🔬Design:Survey & Empirical Study
📍Scope:2003 Verileri
⚙️Variables:Cinsel fonksiyon bozukluğu · fizyolojik · Testosteron

Abstract

Introduction: Lower urinary tract symptoms (LUTS) associated with BPH and erectile dysfunction (ED) are common problems in aging male. In this study, we aimed to determine the causes of the relationship between LUTS and ED, and the possible effects of body mass index (BMI), serum leptin, free testosterone (fT) and lipid levels on LUTS and ED etiology. Materials and Methods: Between June 2003 and February 2004, 46 patients were recruited in this study. All patients underwent physical examination including digital rectal examination, urine analysis, uroflowmetry and residual urine volume assessment. Serum leptin, lipid and free testosterone levels were analyzed. All patients' BMI were determined. Thirty-three patients received alpha blocker treatment and 13 patients were in the watchful waiting group. Erectile capacity and voiding symptoms of the patients were analyzed with International Index of Erectile Function (IIEF-5), International Prostate Symptom Score (IPSS), respectively before and after alpha blocker treatments. Ejaculatory function was assessed with Danish Prostate Symptom Score sexual-function questionnaire (DAN-PSSsex). Data were analyzed using the Pearson correlation test, Mann-Whitney test and Kruskal-Wallis test. Results: There was a negative correlation between IPSS and IIEF (p<0.05). The incidences of ED in patients with LUTS were 50%, 81.8% and 69.2% in patients with mild, moderate and severe symptom, respectively. The frequency of erectile dysfunction was very high in patients especially with moderate symptoms. After alpha blocker treatment the percentage of patients with mild symptoms decreased, but those with moderate and severe symptoms increased. In our study there was no significant correlation between IIEF and fT levels but the mean level of fT in patients with ED was under 15 ng/ml. There was no correlation between serum lipid levels and the other parameters. Conclusion: There is a strong correlation between LUTS and ED. As the severity of LUTS increases the incidence of ED increases. Alpha blocker treatment seems to slightly increase the incidence of ED and ejaculatory problems. Patients with LUTS and ED have lower levels of fT, but this is not statistically significant. There is no correlation between serum lipids and other parameters. Leptin levels might be important in predicting LUTS and ED relationship for future research.

Özet

Çalışmamızda, alt üriner sistem semptomları (AÜSS) ve erektil disfonksiyon (ED) birlikteliğin olası nedenlerini ve bu nedenler ile bazı değişkenlerin (vücut kitle indeksi (VKİ), serum leptin, serbest testosteron (sT), kan lipidleri) ilişkisini incelemeyi amaçladık. Temmuz 2003-Şubat 2004 arası 46 hasta çalışmaya alındı. Tüm hastalara parmakla rektal muayeneyi içeren fizik muayene, tam idrar analizi, idrar akım hızı ve rezidüel idrar volümü incelemesi yapılmıştır. Ayrıca hastaların serum lipid değerleri, serum serbest testosteron düzeyleri ve serum leptin düzeyleri ölçülmüştür. Hastaların VKİ'leri belirlenmiştir. Hastaların semptom süreleri belirlenerek IPSS, IIEF ve DAN-PSS seks soru formları ile tedavi öncesi ve sonrası AÜSS, erektil fonksiyon ve ejakülatuar durumları incelendi. AÜSS skoru ile ED semptom skoru arasında negatif bir korelasyon tespit edilmiştir (p<0.05). Alfa bloker tedavisi sonrası hafif ED sıklığında azalma saptanırken, orta ve şiddetli ED formlarında artış saptanmıştır. IIEF ile serbest testosteron arasında anlamlı bir korelasyon görülmemiştir. Kan lipidleri ile çalışılan hiçbir parametre arasında bağlantı tespit edilmemiştir. Leptin düzeyi ED olan grupta ED olmayan gruba göre daha düşük saptanmıştır. AÜSS için ilaç kullanımı önerilen hastaların çoğunda AÜSS'de gerileme ancak ED'de ve ejakülatuar sorunlarda artış tespit edilmiştir. AÜSS'nin şiddeti arttıkça ereksiyon kaybı da artmaktadır. AÜSS ile gelen ve medikal tedavi ihtiyacı olan hastaların özellikle ED açısından değerlendirilmesi önemlidir. Gelecekteki çalışmalarda, AÜSS ve ED birlikteliğini öngörmede leptin seviyeleri önem kazanabilir.

🔖

Cite This Article

RODOPLU, A., TURNA, B., ALTAY, B., UMUL, M., SEMERCİ, B. (2005). Evaluation of sexual dysfunction in patients with luts, relationship with testosterous, leptin and and serum lipid levels: Re-evaluation after alpha blocker treatment abstract. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 31 - Sayı: 4, 508–515. https://ajindex.com/articles/329013

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Namasivayam S, Minhas S, Brooke J, et al: The evaluation of sexual dysfunction in men presenting with symptomatic benign prostatic hyperplasia. Br J Urol. 82: 842- 846, 1998
  2. O’Leary M: LUTS, ED, QOL: Alphabet soup or real concerns to aging men? Urology. 56 (Sup 1): 7-11, 2000
  3. Rosen R, Altwein J, Boyle P, et al: Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol. 44: 637-49, 2003
  4. Carbone DJ Jr, Hodges S: Medical therapy for benign prostatic hyperplasia: Sexual dysfunction and impact on quality of life. Int J Impot Res. 15: 299-306, 2003
  5. Clifford GM, Farmer RD: Medical therapy for benign prostatic hyperplasia, a review of the literature. Eur Urol. 38: 2-19, 2000
  6. Tarcan T, Azadzoi KM, Siroky MB, et al: Age-related erectile and voiding dysfunction: The role of arterial insufficiency. Br J Urol. 82: 26, 1998
  7. Golomb E, Rosenzweig N, Eilam R, et al: Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl. 21: 58, 2000
  8. Khan MA, Dashwood MR, Thompson CS, et al: Down-regulation of endothelin-B receptor sites in cavernosal tissue of a rabbit model of partial bladder outlet obstruction: Potential clinical relevance. World J Urol. 17: 290, 1999
  9. Bloch W, Klotz T, Loch C, et al: Distribution of nitric oxide synthase implies a regulation of circulation, smooth muscle tone, and secretory function in the human prostate by nitric oxide. Prostate. 33: 1, 1997
  10. Shiri R, Hakkinen JT, Hakama, et al: Effect of lower urinary tract symptoms on the incidence of erectile dysfunction. J Urol. 174: 205-9, 2005
  11. Braun MH, Sommer F, Haupt G, et al: Lower Urinary Tract Syptoms and Erectile Dysfunction: Co-Morbidity or Typical "Aging Male" Symptoms? Result of the "Cologne Male Suvey". Eur Urol. 44: 588-589, 2003
  12. Traish A, Kim NN, Moreland RB, et al: Role of alpha adrenergic receptors in erectile function. Int J Impot Res. 12 (Sup 1): 48-63, 2000
  13. Guiliano F, Bernabe J, Droupy S, et al: A comparison if the effect of tamsulosin and alfuzosin on neurally evoked increases in bladder neck and seminal vesicle pressure in rats. Br J Urol. 93: 605-608, 2003
  14. Mills TM, Reilly CM, Lewis RW: Androgens and penile erection: A review. J Androl. 17: 633-8, 1996
  15. Shabsigh R: The effect of testosterone on the cavernous tissue and erection. World J Urol. 15: 21-6, 1997
  16. Dahle S, Chokkalingam E, Gao Yu-Tang, et al: Body size